Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies
Clinical trial NCT04684472 · UNKNOWN
Trial details
- NCT number
- NCT04684472
- Sponsor
- Liqun Zou
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2023-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.